ANGI vs NCMI

ANGI's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the 7-9 threshold for strong stability. The absence of an Altman Z-Score raises concern over potential distress risk, especially given the company's declining revenue and earnings trends. While the Graham Number ($22.13) suggests undervaluation, the intrinsic value estimate ($6.58) and current price ($7.39) imply a modest premium, unsupported by consistent profitability or growth. The stock has underperformed dramatically over the past 5 years, with a 95.6% decline, and recent earnings misses have been severe, averaging a -32.28% surprise over the last four quarters. These factors collectively point to a fundamentally weak and deteriorating business.

NCMI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. While the company maintains a clean balance sheet with very low debt (Debt/Equity 0.06) and strong liquidity (Current Ratio 2.22), these are offset by negative profit margins and a catastrophic 5-year price decline of 90.7%. The bearish sentiment is further reinforced by aggressive insider selling from the CEO and CFO and a technical trend score of 0/100.